Skanska to sign contract for £330m AstraZeneca UK HQ

An artist's impression of the new facility.
An artist's impression of the new facility.

 

Skanska is said to soon be signing a contract with pharmaceutical giant AstraZeneca for its £330m global headquarters which aims to be a world-renowned centre for life sciences. The firm’s global headquarters is currently in London and will move to Cambridge where this facility will be built.

 

It is anticipated that Skanska will sign a contract imminently to allow building work to commence in the spring.

Earlier this week, final planning was granted for the build which will be located on the Cambridge Biomedical Campus. When complete, it will become Astrazeneca’s largest centre for oncology research, as well as house scientists whose research focuses on cardiovascular and metabolic diseases, respiratory inflammation, autoimmune diseases and conditions of the nervous system.

 

The building was designed by Achitect Herzog & de Meuron, with reference to the historical buildings in Cambridge which are typically designed as low-rise buildings with a central courtyard.

 

Senior Partner, Stefan Marbach, said of the design: “The whole structure is connected in a single loop, providing short connections within the building and modern, innovative workspaces that support collaborative working.

 

“The saw-tooth” roof, which carries on throughout the façade, aims to unify the appearance of the building and give it a distinctive character.”

 

The site has a scheduled completion date of Q4 2016.

Please rate

Comments 

Name
Email
  Ctrl + Enter

Most Read

New Barhale / Doosan JV secures double award

New Barhale / Doosan JV secures double award

The joint venture, which brings together two of the UK’s leading water sector specialist contractors, will undertake infrastructure and non-infrastructure capital projects through the framework including, in the case of Lot 2, civils-led and, under Lot 3, MEICA-led work. Severn Trent, which

Thames Water gets ready to tender £2.6bn AMP7 construction work contracts

Thames Water gets ready to tender £2.6bn AMP7 construction work contracts

Thames' draft AMP7 plan includes a number of complex projects, significant programmes and anticipates a potential increased volume in maintenance activity in response to changing customer and stakeholder needs, population growth and a changing environment. Thames has set out details of the proposed

MWH Treatment wins Severn Trent AMP7 framework contracts

MWH Treatment wins Severn Trent AMP7 framework contracts

We are pleased to hear that our client water sector specialist MWH Treatment has been awarded a place on Severn Trent’s AMP7. The agreement extends an existing 20-year relationship and MWH Treatment (MWHT) will develop and deliver a share of the £2 billion capital works programme,

This website uses cookies to enhance your user experience. By continuing to use this site, you consent to our use of these cookies. See our Cookie Policy.